AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2019
Apr 1, 2019
31676_dirs_2019-04-01_2296ccb2-42c2-42c9-b2a1-c4d06826e5c8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2019-03-28
Reporting Person: Penn Thomas A. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-03-28 | Common Stock | A | 1991 | — | Acquired | 14301 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-03-28 | Stock Options | $66.39 | A | 2409 | Acquired | 2029-03-27 | Common Stock (2409) | Direct |
Footnotes
F1: The restricted stock and stock options vest on March 28, 2020.
More from ANI PHARMACEUTICALS INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Mar 3